CASQ2 and Ventricular arrhythmia: These results show that ivabradine is unable to decrease the ventricular arrhythmias observed in ECG of CASQ2-D307H KI mice, as opposed to TRAM-34, which greatly reduces them (Haron-Khun et al., 2017).